McKesson Achieves 99% Accuracy Distributing 33% of US Prescriptions

McKesson has demonstrated how large-scale automation and digital infrastructure can transform pharmaceutical distribution, achieving more than 99% inventory and order accuracy while handling one-third of all prescriptions dispensed in the United States during fiscal year 2026.

The company's performance metrics, detailed in its FY26 Impact Report, show how procurement strategy and supply chain operations have become central to healthcare delivery. With more than 43,000 employees managing relationships with thousands of suppliers and providers, McKesson operates one of the sector's most complex distribution networks.

Why it matters

Pharmaceutical distribution errors can directly impact patient safety and treatment continuity. McKesson's system prevented 12 million prescription abandonments in FY26, illustrating how backend logistics performance translates to frontline healthcare outcomes. As biologics and specialty therapies requiring precise handling grow, the infrastructure investments McKesson is making may define competitive advantage in healthcare supply chains.

Automated infrastructure at scale

McKesson built its distribution capabilities around digitally connected, automated systems operating across multiple temperature zones. The network accommodates different product requirements, with particular emphasis on advanced cold-chain capabilities for temperature-sensitive treatments.

"We are continuously investing in a digitally enabled supply chain, advanced cold-chain capabilities, automation and AI," CEO and Chair Brian Tyler stated in the report. The infrastructure must handle growing complexity as modern therapies demand specific storage conditions and handling protocols that older logistics systems cannot support.

The company positions itself as critical healthcare infrastructure, delivering medicines and therapies to pharmacies, providers, and hospitals across every care setting.

Workforce preparation for AI integration

McKesson prepared its employees for increased automation by requiring more than 95% of its wired workforce to complete an eight-month learning series focused on digital skills, efficiency, and transformation. The company introduced the McKesson Leadership Prescription, establishing shared behavioral standards for operations in a digital environment.

While the report does not specify which procurement functions will be affected by AI implementation, the training programs suggest the organization anticipates automation expanding across warehousing, distribution, supplier relationship management, order processing, and inventory monitoring.

Supplier network and sustainability targets

McKesson works with approximately 3,300 independent oncology providers through The US Oncology Network, operating a community-based model that positions treatment facilities closer to patients. The network provides practices with access to innovative therapies and clinical trial participation opportunities.

On sustainability, McKesson set a target in FY23 to reduce operational Scope 1 and Scope 2 emissions by 50.4% by FY32, relative to an FY20 baseline. The company reported 72% progress toward that goal as of FY26. Approximately 32% of electricity used by McKesson buildings came from renewable energy sources in FY26.

The company has assessed 52 buildings within its real estate portfolio using proprietary Green Building Standards, awarding 17 certifications. McKesson and the McKesson Foundation contributed more than $17 million to organizations across the US and Canada, with employees volunteering nearly 40,000 hours.

These details were first reported by Procurement Magazine in McKesson's Fiscal Year 2026 Impact Report.